Sun Pharmaceuticals Industries Ltd.
BSE: 524715 | Sector: Health care |
NSE: SUNPHARMA | ISIN Code: INE044A01036 |
BSE 00:00 | 30 Jun | 830.80 |
-7.35 (-0.88%) |
OPEN
842.10 |
HIGH
847.70 |
LOW
823.80 |
NSE 00:00 | 30 Jun | 830.60 |
-8.10 (-0.97%) |
OPEN
836.00 |
HIGH
848.15 |
LOW
823.65 |
OPEN | 842.10 |
PREVIOUS CLOSE | 838.15 |
VOLUME | 258444 |
52-Week high | 966.90 |
52-Week low | 664.10 |
P/E | |
Mkt Cap.(Rs cr) | 199,334 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
About Sun Pharmaceuticals Industries Ltd.
Sun Pharmaceutical Industries Limited including its subsidiaries and associates (Sun Pharma) is the fourth largest global specialty generic company that is ranked No. 1 in India and No. 8 in the US. It is the largest Indian pharmaceutical company in the US and among the leading Indian pharmaceutical companies in emerging markets. The company manufactures and markets a large basket of pharmaceutica...> More
Sun Pharmaceuticals Industries Ltd - Key Fundamentals
Parameter | Values | ||
Market Cap | (![]() |
199,334 | |
EPS - TTM | (![]() |
[*S] | - |
P/E Ratio | (X) | [*S] | - |
Face Value | (![]() |
1 | |
Latest Dividend | (%) | 700.00 | |
Latest Dividend Date | 09 Feb 2022 | ||
Dividend Yield | (%) | 1.20 | |
Book Value / Share | (![]() |
[*S] | 102.48 |
P/B Ratio | (![]() |
[*S] | 8.11 |
News
-
ITC, Sun Pharma: 5 defensive stocks that may gain up to 25%. You own any?
-
Stocks to Watch: M&M, Tata Coffee, Voda Idea, Coal India, Hindalco, REL
-
Sun Pharma plans to expand field force in India by 10% this fiscal
-
Specialty business set to spur growth for Sun Pharma in next 3 yrs: Experts
-
From DRL to Glenmark, pharma companies see steady revenue growth in Russia
Announcement
-
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011
-
Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.
-
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.
-
Sun Pharmaceutical Industries Limited - Closure of trading window
-
Sun Pharmaceutical Industries Limited - Disclosure under SEBI Takeover Regulations
Sun Pharmaceuticals Industries Ltd - Financial Results
Particulars (![]() |
Mar 2022 | Mar 2021 | % Chg |
Net Sales | 9446.76 | 8522.98 | 10.84 |
Other Income | 113.59 | 111 | 2.33 |
Total Income | 9560.35 | 8633.98 | 10.73 |
Total Expenses | 11042.14 | 7147.35 | 54.49 |
Operating Profit | -1481.79 | 1486.63 | -199.67 |
Net Profit | -2222.36 | 848 | -362.07 |
Equity Capital | 239.93 | 239.93 | - |
Sun Pharmaceuticals Industries Ltd - Peer Group
Company | Price(![]() |
Chg (%) | Mkt Cap (![]() |
Sun Pharma.Inds. | 830.80 | -0.88 | 199333.84 |
Divi's Lab. | 3631.00 | 1.30 | 96384.90 |
Cipla | 915.20 | -3.21 | 73847.49 |
Dr Reddy's Labs | 4399.90 | 0.84 | 73231.94 |
Sun Pharmaceuticals Industries Ltd - SHAREHOLDING PATTERN
|
|
Sun Pharmaceuticals Industries Ltd - Research Reports
Sun Pharmaceuticals Industries Ltd - RETURNS
Period | BSE | NSE | Sensex | NIFTY |
1 Week | 0.74% | 0.69% | 1.44% | 1.44% |
1 Month | -6.45% | -6.50% | -5.20% | -5.29% |
3 Month | -9.65% | -9.65% | -8.50% | -8.92% |
6 Month | -0.43% | -0.46% | -8.26% | -8.28% |
1 Year | 22.99% | 22.97% | 1.02% | 0.37% |
3 Year | 107.18% | 107.16% | 34.58% | 33.86% |
Sun Pharmaceuticals Industries Ltd - STOCK STRENGTH
Today's Low/High | 823.80 | 847.70 | |
Week Low/High | 808.15 | 848.00 | |
Month Low/High | 789.75 | 916.00 | |
YEAR Low/High | 664.10 | 967.00 | |
All TIME Low/High | 1.65 | 1201.00 |
Quick Links for Sun Pharmaceuticals Industries:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices